Health Care [ 12/12 ] | Biotechnology [ 64/73 ]
NASDAQ | Common Stock
TAO Synergies Inc. operates as a biopharmaceutical company.
The company is primarily focused on developing a product platform based upon Bryostatin-1, for the treatment of Alzheimer's disease (AD), which is in the clinical testing stage.
It is also evaluating potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
TAO Synergies Inc. was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025.
The company was incorporated in 2012 and is headquartered in New York, New York.n as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025.
The company was incorporated in 2012 and is headquartered in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 28, 25 | 0.04 Increased by +109.78% | - |
| Feb 26, 25 | -4.17 Decreased by -8.07 K% | - |
| Nov 27, 24 | -4.58 Decreased by -13.45 K% | -1.95 Decreased by -134.87% |
| Aug 16, 24 | -1.18 Increased by +14.93% | -1.83 Increased by +35.52% |
| May 15, 24 | -0.41 Decreased by -57.73% | - |
| Feb 28, 24 | -0.05 Increased by +91.90% | -0.38 Increased by +86.58% |
| Nov 13, 23 | -0.03 Increased by +92.14% | -0.37 Increased by +90.86% |
| Aug 14, 23 | -1.39 Decreased by -156.87% | -0.34 Decreased by -307.97% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 0.00 Decreased by -100.00% | 167.84 K Increased by +181.20% | Increased by +N/A% Increased by +N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -5.55 M Decreased by -456.90% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -5.74 M Decreased by -852.36% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -1.27 M Increased by +68.90% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 10.27 K Increased by +N/A% | -206.70 K Increased by +87.92% | Decreased by -2.01 K% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -995.97 K Decreased by -122.22% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | 763.20 K Increased by +124.10% | Increased by +N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -4.09 M Decreased by -7.84% | Decreased by N/A% Decreased by N/A% |